Japanese drugmaker was accused by US pharmacies, retailers of 'pay-for-delay' scheme

Japanese drugmaker was accused by US pharmacies, retailers of 'pay-for-delay' scheme

Takeda plans to appeal after a federal jury found it liable in a landmark pay-for-delay antitrust case and ordered the Japanese drugmaker to pay $885 million in damages, a figure…